|
98
|
309
|
4anqA |
Structure of g1269a mutant anaplastic lymphoma kinase in complex with crizotinib |
|
86
|
294
|
3zonA |
Human tyk2 pseudokinase domain bound to a kinase inhibitor |
|
100
|
318
|
4agcA |
Crystal structure of vegfr2 (juxtamembrane and kinase domains) in complex with axitinib (ag-013736) (n-methyl-2-(3-((e)-2-pyridin-2-yl- vinyl)-1h-indazol-6-ylsulfanyl)-benzamide) |
|
86
|
290
|
4aguA |
Crystal structure of the human cdkl1 kinase domain |
|
90
|
304
|
4a9uA |
Crystal structure of human chk2 in complex with benzimidazole carboxamide inhibitor |
|
116
|
349
|
3zsgA |
X-ray structure of p38alpha bound to tak-715 |
|
105
|
355
|
4aacA |
P38alpha map kinase bound to cmpd 29 |
|
87
|
299
|
4aotA |
Crystal structure of human serine threonine kinase-10 (lok) bound to gw830263a |
|
107
|
337
|
3zo4A |
The synthesis and evaluation of diazaspirocyclic protein kinase inhibitors |
|
104
|
340
|
3zo3A |
The synthesis and evaluation of diazaspirocyclic protein kinase inhibitors |
|
76
|
274
|
4a7cA |
Crystal structure of pim1 kinase with etp46546 |
|
77
|
274
|
4aluA |
Benzofuropyrimidinone inhibitors of pim-1 |
|
74
|
269
|
4af3A |
Human aurora b kinase in complex with incenp and vx-680 |
|
89
|
303
|
4a9rA |
Crystal structure of human chk2 in complex with benzimidazole carboxamide inhibitor |
|
103
|
312
|
4aseA |
Crystal structure of vegfr2 (juxtamembrane and kinase domains) in complex with tivozanib (av-951) |
|
114
|
351
|
4aa4A |
P38alpha map kinase bound to cmpd 22 |
|
91
|
293
|
4ap7A |
Crystal structure of c-met kinase domain in complex with 4-((6-(4- fluorophenyl)-(1,2,4)triazolo(4,3-b)(1,2,4)triazin-3-yl)methyl)phenol |
|
84
|
290
|
4aojA |
Human trka in complex with the inhibitor az-23 |
|
80
|
273
|
4alwA |
Benzofuropyrimidinone inhibitors of pim-1 |
|
85
|
285
|
3zzwA |
Crystal structure of the kinase domain of ror2 |
|
101
|
350
|
4acdA |
Gsk3b in complex with inhibitor |
|
96
|
309
|
4ansA |
Structure of l1196m,g1269a double mutant anaplastic lymphoma kinase in complex with crizotinib |
|
98
|
312
|
3zosA |
Structure of the ddr1 kinase domain in complex with ponatinib |
|
124
|
378
|
3zm9A |
The mechanism of allosteric coupling in choline kinase a1 revealed by a rationally designed inhibitor |
|
87
|
282
|
4an9A |
Crystal structures of human mek1 with carboxamide-based allosteric inhibitor xl518 (gdc-0973), or related analogs. |
|
89
|
310
|
3zutA |
The structure of ost1 (d160a) kinase |
|
110
|
348
|
4aa5A |
P38alpha map kinase bound to cmpd 33 |
|
109
|
347
|
4aa0A |
P38alpha map kinase bound to cmpd 2 |
|
91
|
293
|
4aoiA |
Crystal structure of c-met kinase domain in complex with 4-(3-((1h- pyrrolo(2,3-b)pyridin-3-yl)methyl)-(1,2,4)triazolo(4,3-b)(1,2,4) triazin-6-yl)benzonitrile |
|
81
|
274
|
4alvA |
Benzofuropyrimidinone inhibitors of pim-1 |
|
100
|
303
|
4ag8A |
Crystal structure of the vegfr2 kinase domain in complex with axitinib (ag-013736) (n-methyl-2-(3-((e)-2-pyridin-2-yl-vinyl)-1h- indazol-6-ylsulfanyl)-benzamide) |
|
73
|
279
|
3wzjA |
Crystal structure of human mps1 catalytic domain in complex with 4-(6-(cyclohexylamino)-8-(((tetrahydro-2h-pyran-4-yl)methyl)amino)imidazo[1,2-b]pyridazin-3-yl)-n-cyclopropylbenzamide |
|
118
|
334
|
3wowA |
Crystal structure of human ck2a with amppnp |
|
90
|
292
|
3wf7A |
Crystal structure of s6k1 kinase domain in complex with a purine derivative 1-(9h-purin-6-yl)-n-[3-(trifluoromethyl)phenyl]piperidine-4-carboxamide |
|
100
|
343
|
3zlyA |
Crystal structure of mek1 in complex with fragment 8 |
|
91
|
293
|
3zc5A |
X-ray structure of c-met kinase in complex with inhibitor (s)-6-(1-(6- (1-methyl-1h-pyrazol-4-yl)-(1,2,4)triazolo(4,3-b)pyridazin-3-yl)ethyl) quinoline. |
|
94
|
298
|
3wzdA |
Kdr in complex with ligand lenvatinib |
|
97
|
303
|
3wzeA |
Kdr in complex with ligand sorafenib |
|
82
|
274
|
3zfyA |
Crystal structure of ephb3 |
|
72
|
279
|
3wzkA |
Crystal structure of human mps1 catalytic domain in complex with n-cyclopropyl-4-(8-((thiophen-2-ylmethyl)amino)imidazo[1,2-a]pyrazin-3-yl)benzamide |
|
116
|
334
|
3wikA |
Crystal structure of the ck2alpha/compound10 complex |
|
88
|
287
|
3zmmA |
Inhibitors of jak2 kinase domain |
|
87
|
290
|
3wf5A |
Crystal structure of s6k1 kinase domain in complex with a pyrazolopyrimidine derivative 4-[4-(1h-benzimidazol-2-yl)piperidin-1-yl]-1h-pyrazolo[3,4-d]pyrimidine |
|
93
|
287
|
3zc6A |
Crystal structure of jak3 kinase domain in complex with an indazole substituted pyrrolopyrazine inhibitor |
|
67
|
299
|
3wzuA |
The structure of map2k7 in complex with 5z-7-oxozeaenol |
|
73
|
280
|
3wyxA |
Crystal structure of human mps1 catalytic domain in complex with 6-((3-(cyanomethoxy)-4-(1-methyl-1h-pyrazol-4-yl)phenyl)amino)-2-(cyclohexylamino)nicotinonitrile |
|
71
|
302
|
3wi6A |
Crystal structure of mapkap kinase-2 (mk2) in complex with non-selective inhibitor |
|
87
|
288
|
3wf9A |
Crystal structure of s6k1 kinase domain in complex with a quinoline derivative 1-oxo-1-[(4-sulfamoylphenyl)amino]propan-2-yl-2-methyl-1,2,3,4-tetrahydroacridine-9-carboxylate |
|
101
|
344
|
3zlwA |
Crystal structure of mek1 in complex with fragment 3 |
|
111
|
326
|
3w8lA |
Crystal structure of human ck2 in complex with inositol hexakisphosphate |
